baber/WOPTO huggingface dataset:
Patent JP-H09512515-A (JP)
Title: ヘリコプター用の主回転翼システム
IPC: B64C27/625
Filed: 1995-04-24
Abstract: (57)【要約】
高揚力主回転翼システム（１）がフルサイズヘリコプター又はモデルヘリコプター（１５）用として提供される。主回転翼システム（１）は、空気力学的揚力を作るために回転翼羽根（１００）及び副回転翼羽根（８４）を備える。副回転翼羽根（８４）は主回転翼（１）の制御性と安定性とを増強するように作用する。主回転翼羽根（１００）は、形状が変更していく翼形断面（１０３−１０７）を有するように形作られ、かつ水平方向のフラッピング軸線（１０）まわりに限界内で折り畳まれるように回転翼ハブ（７７）に取り付けられる。操縦士の制御指令を回転している回転翼羽根（１００）に伝達するために、スワッシュプレート（１４０）を含んだリンク装置が提供される。
Patent JP-H11506535-A (JP)
Title: エストロゲン依存性の生理的状態を評価する方法及び装置
IPC: G01N33/68
Filed: 1996-03-25
Abstract: (57)【要約】
エストロゲン依存性の生理的状態を評価する方法及び装置が基板を有し、その基板にアントシアニン色素が適用される。色素は、フリーエストロゲンを吸収する体液の許容量の変化に応答する手段を標示する着色反応を生じる。色素が体液試料に接触させられ、それに対する応答が、着色反応又は吸光度計測により予め設定された生理的状態に照合される。
Patent JP-H10503824-A (JP)
IPC: F17C1/16
Filed: 1995-05-10
Abstract: An internally pressurized fluid vessel, in particular for liquids and/or gases exerting pressure outwards from the container has a sandwich structure capable of withstanding the internal pressure. The vessel has an interior container, an outer jacket in which the container is positioned and a material filling the space between the container and the outer jacket.
Patent JP-2000507186-A (JP)
Title: 封入窓及びその製造法
IPC: B60J10/02
Filed: 1997-12-24
Abstract: (57)【要約】
本発明は、基板の周縁に被覆成形されたプラスチック材料製の枠（５；１６）を備えた一体化又は積層ガラス及び／又はプラスチック基板（４；14）を含む封入窓に関する。枠は、その周縁の少なくとも一部に、基板の縁（６）を掴む実質的にＵ字形の溝を含む。プラスチック材料は、少なくとも１，２００ＭＰａの曲げ弾性率を有する熱可塑性ポリマー又は熱可塑性ポリマーブレンドからなる。場合によって、基板のエッジは、少なくとも部分的に接着下塗剤でコートされる。本発明は特に自動車の固定サイドウインドーに適当である。
Patent JP-2002500678-A (JP)
Title: 過弗素化されたスルホン塩類、およびイオン性伝導材料としてのそれらの使用
IPC: H01M8/00
Filed: 1998-12-01
Abstract: (57)【要約】
本発明は非局在化されたアニオン電荷を有する塩を含む高いイオン伝導率を有するイオン性組成物に関する。イオン性組成物は塩を溶媒中溶液状で含みそして−３０℃〜１５０℃の間で１０ -5 Ｓ・ｃｍ -1 より大きい伝導率を有する。カチオンはプロトン、ヒドロニウム、ヒドロキソニウム、ニトロソニウムＮＯ + 、アンモニウムＮＨ 4   + または金属、有機もしくは有機金属カチオンである。アニオンは過弗素化された置換基を有するカルバニオンまたは対カルバニオンに対するα炭素上に少なくとも１個のＦをそして２個の過弗素化されていない電子−吸引性置換基を有する置換基である。電気化学的装置中での電解質として、化学反応の触媒として、または重合もしくは架橋結合反応用の熱化学的開始剤としての使用。
Patent JP-H10501509-A (JP)
IPC: B65H1/30
Filed: 1996-03-13
Abstract: A partition feeder has a multi-rack assembly for holding more than one reserve stack of partitions. The partition feeder has a main stack of partitions which is forced against a set of tabs and which has its partitions removed by a selecting apparatus. When the main stack has been reduced down past a certain amount, one of the reserve stacks is automatically moved into alignment with the main stack and the partitions in the reserve stack are added to the main stack. The partition feeder has guide rails that are received in notched sides of the partitions, thereby suspending the partitions on the guide rails. An inner frame, upon which the guide rails are mounted, is adjustably mounted to a middle frame to thereby permit the adjustment of the distance between the guide rails. The middle frame is adjustably mounted to an outer frame to permit the vertical adjustment of the mass feeder. The partition feeder can therefore be easily adjusted for partitions of different sizes.
Patent JP-H11503742-A (JP)
Title: ストレプトグラミンの製造方法
IPC: A01N43/72
Filed: 1996-04-16
Abstract: (57)【要約】
Ｒ 1 はメチルまたはエチルであり、Ｒ 2 はＨであり、そしてＸ及びＹは共にオキソ基を形成し、あるいは、Ｒ 1 はエチルであり、Ｒ 2 及びＸはＨであり、そしてＹはＨまたはＯＨであり、さもなければ、Ｒ 1 はエチルであり、Ｒ 2 はＯＨであり、そしてＸ及びＹは共にオキソ基を形成する一般式（Ｉ）のストレプトグラミンを、酢酸媒質中での過ヨウ素酸塩との処理及びそれに続く水性媒質中での処理で、Ｒ 1 、Ｒ 2 、Ｘ、及びＹが上に定義されたとおりであるシネルギスチン（ｓｙｎｅｒｇｉｓｔｉｎ）一般式（II）の誘導体を脱メチル化することにより製造する方法。
Patent JP-2000513763-A (JP)
Title: チタン顔料、その製法および用途
IPC: D21H19/36
Filed: 1998-01-20
Abstract: (57)【要約】
本発明は屋外塗装に用いる新規のチタン顔料に関する。本発明の顔料は、水酸化ジルコニウムまたはオキシ水酸化ジルコニウムの層、次いで水酸化チタンまたはオキシ水酸化チタンの層、次いで燐酸塩とシリカとの共沈層、最後にオキシ水酸化アルミニウム層で順次被覆されたチタン核を持つ。本発明はさらに上記顔料の製造法およびその塗料、プラスチックスおよびラミネート紙への用途に関する。
Patent JP-H11504132-A (JP)
IPC: G02C5/22
Filed: 1996-04-24
Abstract: A method of manufacturing a spring hinge including forming a spring hinge housing and a hinge member of strip materials, and assembling a unitary assembly formed of at lest the hinge member and a spring member by mounting the spring member on the hinge member while the hinge member is still connected with a strip material from which it is formed, with the separation of the hinge member from the strip material after mounting of the spring member on the hinge member.
Patent JP-2002513396-A (JP)
Title: 高度に不溶性な白金錯体の脂質複合体及びリポソーム
IPC: A61K47/48
Filed: 1998-01-28
Abstract: (57)【要約】
リン脂質と水不溶性なジカルボン酸白金の脂質複合体またはリポソームを含む薬剤組成物及びそのような組成物の調製方法が開示される。
Patent JP-2000515410-A (JP)
Title: 皮膚科治療用ペルチエ冷却装置及び方法
IPC: A61B18/00
Filed: 1998-01-13
Abstract: (57)【要約】
皮膚疾患を放射線照射により処置する装置であり、患者の皮膚の治療領域を冷却するためのペルチエ冷却装置２０を有する。ペルチエ冷却装置は患者の皮膚の治療領域と熱的に接触しうる低温面と高温面と、これらの面間に延びる開口３０を有し、この開口を通して放射線の照射が行われる。一つの実施形態ではペルチエ冷却装置２０の開口内に設けたレンズ８０は冷却を治療領域に実質的に均一に分布させる。温度センサ７０が治療領域の温度を感知してペルチエ冷却装置２０及び又は放射線源の制御を行うのに使用されて所定温度を超えないように保証する。放射線源としてはレーザ、ガス放電ランプ例えばアークランプ、閃光ランプがある。
Patent JP-H11504954-A (JP)
Title: 印刷インク用非芳香族系溶媒
IPC: C09D11/033
Filed: 1996-04-26
Abstract: (57)【要約】
溶媒混合物を構成する、印刷インキ用の芳香族化合物非含有溶媒であって、ａ）非芳香族系化合物非含有鉱油８０〜９９重量％、ｂ）６０までの総炭素原子数を有するＣ 8   〜22 脂肪酸のエステル１〜２０重量％および／またはｃ）６〜３６の炭素原子を含む脂肪アルコール１〜２０重量％を含むことを特徴とする溶媒を開示する。また、バインダー、色素および芳香族化合物非含有溶媒を含むと共に、所望により添加剤を含む印刷インクを開示する。
Patent JP-2000507944-A (JP)
IPC: A61K38/22
Filed: 1997-03-17
Abstract: Compositions of proteins with chondrocyte and cartilaginous tissue inducing activity, as well as method of using those compositions, are disclosed. The compositions comprise one or more proteins of the transforming growth factor- beta  (TGF- beta ) superfamily of proteins, particularly bone morphogenetic proteins (BMPs), in combination with parathyroid hormone related polypeptide (PTHrP) or an equivalent PTH-like polypeptide. The compositions and methods are useful in the treatment of osteoarthritis, cartilage defects and in related tissue repair.
Patent JP-2001510595-A (JP)
IPC: G10L15/02
Filed: 1998-07-22
Abstract: A vocoder based voice recognizer recognizes a spoken word using linear prediction coding (LPC) based, vocoder data without completely reconstructing the voice data. The recognizer generates at least one energy estimate per frame of the vocoder data and searches for word boundaries in the vocoder data using the associated energy estimates. If a word is found, the LPC word parameters are extracted from the vocoder data associated with the word and recognition features are calculated from the extracted LPC word parameters. Finally, the recognition features are matched with previously stored recognition features of other words, thereby to recognize the spoken word.
Patent JP-2001515388-A (JP)
Title: 経口挿管ガイド
IPC: A61M16/04
Filed: 1998-03-13
Abstract: (57)【要約】
経口気管チューブ６０がガイド１０を通って前進するにつれ、このようなチューブ６０が引っかかるのを防止するよう、喉頭蓋９０に効果的に張り出したチューブ支持樋５０を伴い、チューブを受ける空間４６を含む盲目挿管ガイド１０。ガイド壁４２は、チューブ６０を喉頭口８２内に向け、ガイドの樋５０と後部材１６と支持部材３０との接合部のレベル９３より下に上縁９２を有し、樋５０の自由縁５２と協力して、チューブ６０を、喉頭口８２および気管９６内へと前進させるための位置に回転させる。
Patent JP-2001521504-A (JP)
Title: メタロプロテイナーゼ阻害薬、それらを含有する薬剤組成物および薬剤としてのそれらの使用
IPC: A61P35/00
Filed: 1998-03-31
Abstract: (57)【要約】
式Ｉの化合物：
 (式中、ＹはＯまたはＳであり；Ａｒはアリール基またはヘテロアリール基であり；Ｒは水素、アルキル基、シクロアルキル基、ヘテロシクロアルキル基、アリール基、ヘテロアリール基、または−Ｃ（Ｏ）Ｒ 1 であり、ここでＲ 1 は水素、アルキル基、シクロアルキル基、ヘテロシクロアルキル基、アリール基、ヘテロアリール基またはＮＲ 2 Ｒ 2 であり、ここでＲ 2 およびＲ 2 は独立して水素、アルキル基、シクロアルキル基、ヘテロシクロアルキル基、アリール基またはヘテロアリール基であり；Ｘは−ＮＨ−ＯＨまたは−ＯＨである)。これらの化合物の薬剤学的に許容しうるプロドラッグ、塩もしくは溶媒和物。式Ｉの化合物、またはプロドラッグ、塩もしくは溶媒和物を投与することによる、メタロプロテイナーゼ活性の阻害方法。有効量のこれらの化合物、プロドラッグ、塩もしくは溶媒和物を含む薬剤組成物。
Patent JP-2001524172-A (JP)
Title: 伸び改良樹脂からなる抄紙用ベルト
IPC: D21F11/00
Filed: 1998-04-29
Abstract: (57)【要約】
改良された伸びを有する樹脂状高分子重合体を含有する製紙用ベルト。本発明の製紙用ベルトは強化用構成要素と樹脂状高分子重合体を含有し、又樹脂状高分子重合体は、耐クリープ性を保持しながら又いかなる過度の引張強さ減少も伴わずに、常温及びより高い温度で改良された伸びを発揮する。製紙用ベルトに加えて、本発明の樹脂状高分子重合体は又他の利用法に使用してもよい。
Patent NZ-199807-A (NZ)
Title: Converting olefines to alpha-epoxy alcohols
Inventor: MIHELICH E D
IPC: C07D303/14
Filed: 1982-02-23
Abstract: A novel process for the oxidation of olefins to the corresponding alpha-epoxy alcohols which can be incorporated in the total synthesis of members of a novel class of prostaglandin analogues. Olefins are reacted with singlet oxygen in the presence of a group IVB, VB or VIB transition metal catalyst, excluding chromium. The reaction is fast and highly selective to the alpha-epoxy alcohol. When cyclopentene is oxidized in the process of the invention, high yields of cis 2,3-epoxy-cyclopentan-1-ol are obtained. The latter compound is used as a starting material in the synthesis of prostaglandin analogues. The prostanoids of the invention are characterized by an oxa group replacing the methylene group at the 7-position, and the absence of a hydroxyl or other substituent at the 11-position. Members of this class of prostanoids show important cytoprotective properties in animal tests.
Patent NZ-200852-A (NZ)
Title: Preparation of 2-(thien-2-yl)-and 2-(thien-3-yl)-ethylamine derivatives
Inventor: HEYMES A
IPC: C07D333/32
Filed: 1982-06-04
Abstract: R1-substd.-2- or 3-thienyl-CHR2-CHR3-NH-CHR4-Ar derivs. of formula (I) are prepd by (a) condensation of a phosphonate, phosphinate, phosphene oxide or phosphonamide deriv. of formula XYP(O)-CHR3-NH2 (II), with a carbonyl cpd. Ar-CO-R4 (III) to form XYP(O)-CHR3-N=CR4-Ar (IV); (b) treatment of (IV) with a base B(-)M(+) to form the carbanion XYP(O)-CR3M(+)-N=CR4-Ar (V); (c) (V) is reacted with a thiophene-carbonyl cpd. R1-thienyl-CO-R2 (VII) to form R1-thienyl-CR2=CR3-N=CR4-Ar (VIII) which is reduced to yield (I) (where R1 in posn. 2, 3, 4 or 5 is H, halo, nitro, carboxy, cyano, amino, opt. branched alkyl, opt. branched alkoxy, aryl or aromatic heterocyclic (opt. mono- or poly-substd. by halo, nitro, cyano, amino, carboxy, alkyl, alkoxy or phenyl). The amino-ethyl side chain is joined to the thiophene ring at posns. 2 or 3; R2, R3, R4 are H, aryl or aromatic heterocyclic (opt. mono- or poly-substd. by halo, nitro, cyano, amino, carboxy, alkyl, alkoxy or phenyl); Ar is aryl or aromatic heterocyclic (opt. mono- or poly-substd. by alkyl, phenyl, halo, nitro, cyano, amino, carboxy or alkoxy); X, Y independently are alkyl, alkoxy, aryl, aryloxy, dialkyl or diaryl-amino. The base B-M+ may be an alkali metal hydride, amide or alkylamide, an organometallic cpd. e.g. n-butyllithium or an alkali metal or alkaline earth alcoholate or hydroxide. Some of cpds. (I) are new. (I) are chemical and pharmaceutical intermediates e.g. for tetrahydrothieno(3,2-c)pyridines and thieno(2,3-c)pyridines, which have therapeutic use (see French applicn. 73.03503, 75.03968, 75.20241, 75.23788, 75.24486, 76.00003 and 77.21517).
Patent NZ-201454-A (NZ)
Title: Retractable foot-step for vehicle
Inventor: BRYNIELSSON T
IPC: B60R3/02
Filed: 1982-08-02
Abstract: The foot-step is operable by a mechanism including a guide device below the floor of the vehicle for extension of the step outside one side of the vehicle in an outwards/downwards movement and retraction in the opposite direction. 
<??>The foot-step comprises a support structure (3) over which an endless mat (18) is stretched, and means for retaining a portion (19) of the mat (18) in the direction of movement of the foot-step, but not in the vertical direction.
Patent NZ-216967-A (NZ)
Title: Fusion protein containing elements of the trp operon of e.coli, plasmids and transformants
Inventor: HABERMANN P
IPC: C07K19/00
Filed: 1986-07-25
Abstract: 1. Claims for the Contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE A fusion protein of the general formula Met - Xn - D' - Y - Z in which n is zero or 1, X is a sequence of 1 to 12 genetically codable amino acids, D' is a sequence of about 70 amino acids in the region of the sequence of amino acids 23 - 93 of the D-peptide in the trp operon of E. coli, Y denotes a sequence of one or more genetically codable amino acids which permits the following amino acid sequence Z to be cleaved off, and Z is a sequence of genetically codable amino acids. 1. Claims for the Contracting State : AT A process for the preparation of a fusion protein of the general formula (1) Met - Xn - D' - Y - Z in which n is zero or 1, X is a sequence of 1 to 12 genetically codable amino acids, D' is a sequence of about 70 amino acids in the region of the sequence of amino acids 23 - 93 of the D-peptide in the trp operon of E. coli, Y denotes a sequence of one or more genetically codable amino acids which permits the following amino acid sequence Z to be cleaved off, and Z is a sequence of genetically codable amino acids, characterized by expressing a gene structure which codes for these fusion proteins in a host cell, and separating the fusion protein.
Patent NZ-217900-A (NZ)
Title: Fertiliser granules containing urea and ammonium sulphate
Inventor: VANMARCKE L A
IPC: C05C13/00
Filed: 1986-10-13
Abstract: The invention concerns a method of producing fertilizer granules containing urea and ammonium sulphate by granulating a mixture containing urea, ammonium sulphate and water, which is characterized in that the ammonium sulphate is completely dissolved in an aqueous urea solution with a urea concentration of 70-85% by weight, the resulting solution is thickened to a dry content of 92-97% by weight, with a crystallization retarder for the urea being added in any stage of the treatment, following which the thickened solution is granulated in a fluidized bed of urea and ammonium sulphate containing nuclei, as well as urea, ammonium sulphate and crystallization retarder containing granules.
Patent NZ-223506-A (NZ)
Title: Tissue factor protein, dna encoding it, vectors, host cells, production of the protein and pharmaceutical compositions
Inventor: LAWN RICHARD MARK
IPC: C12N15/12
Filed: 1988-02-12
Abstract: DNA isolates coding for tissue factor protein and derivatives thereof and methods of obtaining such DNA and producing tissue factor protein and derivatives thereof using recombinant expression systems for use in therapeutic compositions for the treatment of coagulation disorders. <IMAGE>   <IMAGE>
Patent NZ-228897-A (NZ)
Title: Imidazolylalkyl benzamide derivatives and pharmaceutical compositions; processes for preparation
Inventor: COSSEMENT ERIC
IPC: C07D233/64
Filed: 1989-04-26
Abstract: New substituted 1-(1H-imidazol-4-yl)alkyl-benzamides and their salts, processes for the preparation thereof and pharmaceutical compositions. These compounds have the formula  <IMAGE>  wherein R1, R2=hydrogen or C1-C4-alkyl, R3=hydrogen, amino, hydroxyl, C1-C4-alkyl or C1-C4-hydroxyalkyl, R4=hydrogen or C1-C4-alkyl, or R3R4N=pyrrolidino, piperidino or morpholino, R5 and R6=hydrogen, hydroxyl, C1-C4-alkyl or C1-C4-alkoxy, at least one of R5 and R6 being other than hydrogen. These compounds are prepared either by reacting a nitrogen compound with an alkyl 1-(1H-imidazol-4-yl)alkyl-benzoate or with a 1-(1H-imidazol-4-yl)alkyl-benzoic acid, or by hydrolyzing in an acid medium a 2-hydroxy-3-[1-(1H-imidazol-4-yl)alkyl]-benzonitrile. The compounds have anti-ischemic and  alpha 2-adrenoceptor agonist activities.
Patent NZ-238580-A (NZ)
Title: Pharmaceutical composition comprising cephalosporin and xanthine(s); methods of treatment
Inventor: KLESEL NORBERT
IPC: A61P9/00
Filed: 1991-06-18
Abstract: Pharmaceutical combination products containing at least one cephalosporin derivative and at least one xanthine derivative are suitable for the prophylaxis and treatment of bacterial infectious diseases and for the prophylaxis and treatment of septic shock.
Patent NZ-242869-A (NZ)
Title: Treatment of diseases of the human respiratory tract using a suspension of lipids and proteins containing bound-calcium and/or magnesium ions
Inventor: DISSE BERND
IPC: A61K38/16
Filed: 1990-07-03
Abstract: The surfactant suspensions are used for replacement therapy in respiratory tract disorders. The suspensions contain calcium and/or magnesium ions bound to the surfactant and unbound in the suspending agent and have a defined content of sodium chloride.
Patent NZ-257528-A (NZ)
Title: Gas fluidisation; details of openings in a bed plate in apparatus for treating particulate material with a gas
Inventor: CHRISTENSEN MOGENS AXEL
IPC: B01J8/36
Filed: 1993-09-30
Abstract: A bed plate for a fluidized bed defines a plurality of substantially uniformly distributed openings therein for allowing fluidizing gas to flow upwardly through the plate. The openings (22) are divided into pairs and directed and shaped so that the gas flows (24) through the openings of each pair are directed in converging relationship so as to create a resultant flow component (29), which is directed towards a discharging position of the fluidized bed. The desired resultant flow component may be obtained by properly selecting the direction and shape of the openings (22) in each pair of openings. The gas flows through the openings in each pair may, for example, define an angle (v) of 60 DEG -120 DEG  therebetween. <IMAGE>
Patent NZ-292922-A (NZ)
Title: 5-sulphonylamino(and sulphonylalkyl)-2,3-dioxoquinoxaline derivatives
Inventor: FRAY MICHAEL JONATHAN
IPC: C07D/
Filed: 1995-09-08
Abstract: PCT No. PCT/EP95/03559 Sec. 371 Date Mar. 21, 1997 Sec. 102(e) Date Mar. 21, 1997 PCT Filed Sep. 8, 1995 PCT Pub. No. WO96/09295 PCT Pub. Date Mar. 28, 1996Compounds of formula (I), wherein A represents N or CH; R1 and R2 independently represent C1-4 alkyl, halo or CF3; R3 represents C1-4 alkyl (optionally substituted), C3-7 cycloalkyl, CF3 or aryl; R4 represents H, C3-7 cycloalkyl or C1-6 alkyl (optionally substituted); and their pharmaceutically acceptable derivatives; are useful in the treatment of, inter alia, neurodogenerative disorders.
Patent NZ-295744-A (NZ)
Title: Frozen suspension of gas bubbles; the liquid suspension being used as an injectable contrast agent
Inventor: YAN FENG
IPC: A61K49/00
Filed: 1995-12-14
Abstract: Disclosed are suspensions of gas microbubbles immobilised within a frozen aqueous carrier liquid comprising usual additives and stabilisers, in which the carrier liquid is a physiologically acceptable, the immobilised gas microbubbles are microbubbles bound by an evanescent envelope or a tangible membrane. The suspensions, when in liquid form, are injectable and useful as a contrast agents in ultrasonic imaging of blood pool and tissue of living beings. The gas microbubbles are immobilised within the carrier by freezing a suspension of microbubbles with average sizes below 50  mu m, preferably below 10  mu m and more preferably between 2  mu m and 8  mu m, to a temperature between -1 DEG  C. and -76 DEG  C. and maintaining this temperature for prolonged periods of time. The microbubbles may be stabilised by a surfactant such as a lamellar phospholipid or may comprise a membrane made of synthetic or natural polymer or protein. A method of cold storage of microbubble suspensions as well as their use is also disclosed.
Patent NZ-307227-A (NZ)
Title: 1 Phenylpyrazole-3-carboxamide derivatives and pharmaceutical compositions
Inventor: LABEEUW BERNARD
IPC: C07D231/12
Filed: 1996-04-11
Abstract: he compound of formula I or its salts and quaternary ammonium salts formed with acyclic or cyclic tertiary amines and it solvates wherein: R1 is -T-CN, -C(NH2)=NOH, -C(=NOH)-NH-(CH2)rNR5R6, -T-C(NR12R13)=NR14, -C(NH2)=NO(CH2)rNR5R6, -T-CONRaRb, -T-CONR7RC, ORd, -T-N(R7)CORe, -SO2NRaRb, -T-N(R7)-SO2R'7  or -T-NR27R28; R2 and R3 independently are H, alkyl, cycloalkylmethyl, cycloalkyl, halo, nitro, trifluoromethyl, -OR4, -NR5R6, 1-pyrrolyl, cyano or carbamoyl or R2 and R3 together form a trimethylene, tetramethylene or pentamethylene group; R4 is H, alkyl, alkenyl, cycloalkylene, cycloalkylmethyl, alkoxyalkylene or benzyl and the rest of the variables are as defined in the specification is claimed. the compounds of formula I have an affinity to human neurotensin receptors.
Patent NZ-332406-A (NZ)
Title: Personalising smart cards using database of card issuer data format templates
Inventor: TUSHIE DAVID R
IPC: G06Q40/00
Filed: 1997-04-14
Abstract: A smart card personalization system maintains a database containing card issuer data format templates, card applications, card operating system commands, and personalization equipment specifications.  It provides a centralized interface of inputs and outputs to a card issuing process which adjusts to changes in the issuing process to easily permit a card issuer to change data formats, card applications, card operating systems and/or personalization equipment in a card issuing process. The system interfaces to any card issuer management system, manages the transfer of card holder data and card applications to the particular personalization equipment used, and maintains statistics for real-time and off-line inquiries to support critical management and reporting functions.  The system works with a variety of security methodologies to prevent fraud.
Patent NZ-333746-A (NZ)
Title: Alarm system for fishing rod reel, activated by fish taking bait
Inventor: ARMSTRONG LEWIS GEOFFREY
IPC: A01K97/12
Filed: 1999-01-15
Abstract: A fishing rod "fixed reel" with line wind-up performed by a bail and spool rotation only when sufficient tension is applied to the line, is fitted with a device for sensing rotation of the reel.  The sensor consists of a printed circuit board 16 fitted within the reel housing 13 over the spool shaft and a cover 15 that forms also a drag nut that can be tightened or loosened on the threaded end of the spool shaft to change the drag of the reel.  The board mounts a pair of conical springs 20, 21, green and red LEDs 22, 23 and/or an audible buzzer, and reed switches which are activated by a magnet mounted on the spool. The flashing green LED indicates a standby mode with the magnet set over the appropriate reed switch, and when a fish strikes, the green LED is deactivated because the magnet moves, and the red LED is activated.  If the fish runs with the line the red LED will be activated flickeringly. Moreover, because the device is part of the drag mechanism for the reel, setting of the drag will influence under what circumstances the device signals the fish strike and run, in particular, the red LED is not activated by existing tension on the line.
Patent NZ-334667-A (NZ)
Title: A reverse genetics system for dsRNA viruses that generates birnavirus, such as infectious bursal disease virus, from synthetic RNA transcripts
Inventor: VAKHARIA VIKRAM N
IPC: A61K39/00
Filed: 1997-07-31
Abstract: This system is for the generation of live Birnavirus such as infectious bursal disease virus (IBDV), a segmented double-stranded (ds)RNA virus of the Birnavirdae family, using synthetic transcripts derived from cloned DNA.  Independent full-length cDNA clones were constructed which contained the entire coding and non-coding regions of RNA segments A and B of IBDV, respectively.  Synthetic RNAs of both segments were produced by in vitro transcription of linearized plasmids with T7 RNA polymerase. Transfection of Vero cells with combined plus-sense transcripts of both segments generated infectious virus as early as 36 hours post-transfection.  The development of a reverse genetics system for dsRNA viruses will facilitate studies of the regulation of viral gene expression pathogenesis, and design of a new generation of live and inactivated vaccines.
Patent NZ-334960-A (NZ)
Title: Method of filling a capsule with fluid helium at a pressure of 30 bars
Inventor: GARRETT MICHAEL ERNEST
IPC: F17C13/00
Filed: 1999-03-31
Abstract: A method of filling a capsule having a hollow body portion and a hollow neck portion extending from it with fluid under pressure comprising the steps: a) applying in a fluid tight manner a filling cap to the free end of the neck portion initially to evacuate the hollow body portion and subsequently to fill the hollow body portion with the fluid under pressure; b) with the filling cap in place and pressure applied at least 30 bars, crimping the neck portion at a location spaced from the free end of the neck portion; c) removing the filling cap and thereby revealing the free end of the neck portion d) applying a second crimp at or immediately adjacent the free end of the neck portion; e) welding the free end to seal the capsule which can be made from aluminum or an aluminum alloy.